Page 82 - Sohini Das

Coronavirus vaccine shot may cost Rs 1,000 in private market: Sources

Could be priced at Rs 600-650/dose for institutional sales

Prioritise country first, PM Modi tells Covid-19 vaccine makers

"He has asked the industry to prioritise deliveries to meet the country's needs first and then focus on global supplies," said a person in the know, who did not wish to be named.

Serum, Bharat Biotech to get suppliers' credit for 300 mn Covid-19 doses

Govt okays Rs 4,500 cr upfront payment for 300 mn doses

Mankind Pharma eyes 50% revenue from chronic therapy drugs in 3 years

With the launch, the company has become the first Indian and second global firm to develop the drug, which is a generic version of Abbott's Duphaston

Covid-19: Remdesivir output to be doubled to 7.4 mn doses by April-end

18 new sites get DCGI consent to make antiviral used for treating Covid-19

From Sputnik V to Moderna, here's a snapshot of Covid-19 vaccines

Of this list, Sputnik V is already approved in India and Sinovac is unlikely to come in as it does not meet the aforementioned criteria

Adar Poonawalla urges US Prez to lift ban on export of vaccine raw material

Poonawalla had said earlier that US curbs were hampering scale-up of Novavax vaccine at Pune. Serum has collaborated with Novavax of US to make its vaccine here and supply to Covax at $3 a shot

Govt push to step up Covid-19 vaccine output 10 times by September

Bharat Biotech and 3 PSEs to ramp up Covaxin production capacity

Covid-19 vaccination: Too early to say if booster dose needed, say experts

Pfizer CEO has said a 3rd booster shot likely within a year of vaccination

Behind India's ventilator crisis: Lack of trained staff and idle units

Oxygen makers flag concern over shortage of liquid oxygen

Decision in 3 working days after foreign Covid-19 vaccine firms apply

Many vaccine makers in talks with govt as India wants a portfolio of products

The second wave: Covid-19 testing labs look at ways to ramp up capacity

Now demand is growing almost 100 per cent week-on-week, leading to a testing crisis, said an industry insider.

Dr Reddy's to also use govt cold chain infra for Sputnik V distribution

The vaccine would be transported in frozen form by air and road

Shortage of key chemical hits Bharat Biotech's Covaxin ramp-up plans

Bharat Biotech is trying to ramp up capacities of Covaxin to 12 million doses per month by July, from the current 5 million doses per month

Clinical trials on India's first mRNA Covid-19 vaccine to begin soon

Gennova's Covid vaccine candidate HGCO19 would remain stable at 2 to 8 degree Celsius temperature

Second Covid-19 wave: Hospitals running out of beds, staff overstretched

A year later, non-Covid treatments fall off priority list again

India fast-tracks emergency use of foreign-made Covid-19 vaccines

No need for prior local clinical trials for vaccines cleared by regulators

Govt slams states: No Covid-19 vaccine shortage, only poor planning

Rajesh Bhushan, Union health secretary, said that there were over 20 million doses in the pipeline to be distributed to states

Covid-19 vaccine Sputnik V gets DCGI nod; may be available by May

Russian Covid-19 vaccine granted restricted emergency-use authorisation in India

India gets third Covid-19 vaccine as SEC clears Russia's Sputnik V

Final nod from DCGI soon, jab likely at $3/dose